Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

February 12, 2010
Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights

February 10, 2010
Bioniche Reports Fiscal 2010 Second Quarter Results

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Shareholder Information

Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.

Contact information:

CIBC Mellon Trust Company
P.O. Box 7010
Adelaide St. Postal Station
Toronto, Ontario M5C 2W9
Tel: (416) 643-5500
Toll free: (800) 387-0825
Fax: (416) 643-5501
E-mail: inquiries@cibcmellon.com

Bioniche financial reports can be downloaded here

Request investor materials by regular mail here

All Bioniche publicly-listed documents can be viewed here

E-mail Alerts

To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy